Results of the Afatinib Expanded Access Program (EAP): Efficacy and Safety: Metastatic Non-Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Results of the Afatinib Expanded Access Program (EAP): Efficacy and Safety: Metastatic Non-Small Cell Lung Cancer.
Authors: Kim, E.S.1, Halmos, B.2, Kohut, I.F.3, Patel, T.4, Rostorfer, R.D.5, Spira, A.I.6, Cseh, A.7, McKay, J.8, Wallenstein, G.9, Mileham, K.F.1
Source: International Journal of Radiation Oncology, Biology, Physics. Nov2014 Supplement, Vol. 90 Issue 5, pS40-S40. 1p.
Subjects: Protein-tyrosine kinase inhibitors, Drug efficacy, Lung cancer treatment, Medication safety, Metastasis
Database: Engineering Source
Description
ISSN:03603016
DOI:10.1016/j.ijrobp.2014.08.221